The Food and Drug Administration this year expanded the indications for taking rosuvastatin (Crestor), a particularly powerful statin, to include some people with a normal LDL level if they have a high level of C-reactive protein (CRP), a marker for inflamed coronary arteries.
Source: http://feeds.washingtonpost.com/click.phdo?i=e74f699d9aeeafe6ce6405e5f9a84e07
Chrome OS Elizabeth Edwards E-books Kate Gosselin
No comments:
Post a Comment